Sfoglia per Autore
Synthesis of new pyrazolo[3,4-d]pyrimidines 6-alkyl substituted Bcr-Abl tyrosine kinase inhibitors
2010-01-01 Musumeci, F.; Schenone, S.; Brullo, C.; Bruno, O.; Botta, M.
Novel dual Src/Abl inhibitors for hematologic and solid malignancies.
2010-01-01 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Botta, M.
A1 receptors ligands: past, present and future trends.
2010-01-01 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Bruno, Olga; Botta, M.
Src kinase inhibitors: an update on patented compounds
2011-01-01 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Radi, M.; Castagnolo, D.
One-pot synthesis of indolyl- pyrrolones as Pim1 inhibitors
2011-01-01 Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; M., Radi; M., Botta
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells
2011-01-01 Radi, M.; Brullo, C.; Crespan, E.; Tintori, C.; Musumeci, F.; Biava, M.; Schenone, S.; Dreassi, E.; Zamperini, C.; Maga, G.; Pagano, D.; Angelucci, A.; Bologna, M.; Botta, M.
Selective chemical oxidation of risperidone: a straightforward and cost-effective synthesis of paliperidone
2011-01-01 Riva, Renata; Banfi, Luca; Castaldi, G; Ghislieri, D; Malpezzi, L; Musumeci, Francesca; Tufaro, R; Rasparini, M.
Substituted pyrazolo[3,4-b]pyridines as human A(1) adenosine antagonists: Developments in understanding the receptor stereoselectivity
2011-01-01 Tuccinardi, T; Zizzari, At; Brullo, Chiara; Daniele, S; Musumeci, Francesca; Schenone, Silvia; Trincavelli, Ml; Martini, C; Martinelli, A; Giorgi, G; Botta, M.
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study.
2011-01-01 Radi, M; Dreassi, E; Brullo, Chiara; Crespan, E; Tintori, C; Bernardo, V; Valoti, M; Zamperini, C; Daigl, H; Musumeci, Francesca; Carraro, F; Naldini, A; Filippi, I; Maga, G; Schenone, Silvia; Botta, M.
Fyn kinase in brain diseases and cancer: the search for inhibitors.
2011-01-01 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Biava, M; Falchi, F; Botta, M.
ATP-competitive inhibitors of mTOR: an update.
2011-01-01 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Radi, M; Botta, M.
Synthesis of pyrazolo[3,4-d]pyrimidine derivatives active against the T315I Abl mutation.
2012-01-01 Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Maga, G.; Botta, M.
Synthesis of pyrazolo[3,4-d]pyrimidine derivatives endowed with activity against the T315I Abl mutation
2012-01-01 Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; G., Maga; M., Botta
An update on dual Src/Abl inhibitors
2012-01-01 Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Botta, M.
A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: From in silico screening to cyclodextrin formulation.
2012-01-01 Radi, M; Evensen, L; Dreassi, E; Zamperini, C; Caporicci, M; Falchi, F; Musumeci, Francesca; Schenone, Silvia; Lorens, Jb; Botta, M.
Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors.
2012-01-01 Musumeci, Francesca; Radi, M; Brullo, Chiara; Schenone, Silvia
Synthesis of pyrazolo[3,4-d]pyrimidines active on Bcr-Abl T315I mutation.
2013-01-01 Musumeci, Francesca; Desogus, A.; Brullo, Chiara; Tintori, C.; Fallacara, A.; Maga, G.; Crespan, E.; Radi, M.; Schenone, Silvia
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors.
2013-01-01 Mori, M; Tintori, C; Christopher, Rs; Radi, M; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Sanità, P; Delle Monache, S; Angelucci, A; Kissova, M; Crespan, E; Maga, G; Botta, M.
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors
2013-01-01 G., Vignaroli; C., Zamperini; E., Dreassi; M., Radi; A., Angelucci; P., Sanità; E., Crespan; M., Kissova; G., Maga; Schenone, Silvia; Musumeci, Francesca; M., Botta
Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutant.
2013-01-01 Radi, M; Tintori, C; Musumeci, Francesca; Brullo, Chiara; Zamperini, C; Dreassi, E; Fallacara, Al; Vignaroli, G; Crespan, E; Zanoli, S; Laurenzana, I; Filippi, I; Maga, G; Schenone, Silvia; Angelucci, A; Botta, M.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Synthesis of new pyrazolo[3,4-d]pyrimidines 6-alkyl substituted Bcr-Abl tyrosine kinase inhibitors | 1-gen-2010 | Musumeci, F.; Schenone, S.; Brullo, C.; Bruno, O.; Botta, M. | |
Novel dual Src/Abl inhibitors for hematologic and solid malignancies. | 1-gen-2010 | Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Botta, M. | |
A1 receptors ligands: past, present and future trends. | 1-gen-2010 | Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Bruno, Olga; Botta, M. | |
Src kinase inhibitors: an update on patented compounds | 1-gen-2011 | Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Radi, M.; Castagnolo, D. | |
One-pot synthesis of indolyl- pyrrolones as Pim1 inhibitors | 1-gen-2011 | Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; M., Radi; M., Botta | |
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cells | 1-gen-2011 | Radi, M.; Brullo, C.; Crespan, E.; Tintori, C.; Musumeci, F.; Biava, M.; Schenone, S.; Dreassi, E.; Zamperini, C.; Maga, G.; Pagano, D.; Angelucci, A.; Bologna, M.; Botta, M. | |
Selective chemical oxidation of risperidone: a straightforward and cost-effective synthesis of paliperidone | 1-gen-2011 | Riva, Renata; Banfi, Luca; Castaldi, G; Ghislieri, D; Malpezzi, L; Musumeci, Francesca; Tufaro, R; Rasparini, M. | |
Substituted pyrazolo[3,4-b]pyridines as human A(1) adenosine antagonists: Developments in understanding the receptor stereoselectivity | 1-gen-2011 | Tuccinardi, T; Zizzari, At; Brullo, Chiara; Daniele, S; Musumeci, Francesca; Schenone, Silvia; Trincavelli, Ml; Martini, C; Martinelli, A; Giorgi, G; Botta, M. | |
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study. | 1-gen-2011 | Radi, M; Dreassi, E; Brullo, Chiara; Crespan, E; Tintori, C; Bernardo, V; Valoti, M; Zamperini, C; Daigl, H; Musumeci, Francesca; Carraro, F; Naldini, A; Filippi, I; Maga, G; Schenone, Silvia; Botta, M. | |
Fyn kinase in brain diseases and cancer: the search for inhibitors. | 1-gen-2011 | Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Biava, M; Falchi, F; Botta, M. | |
ATP-competitive inhibitors of mTOR: an update. | 1-gen-2011 | Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Radi, M; Botta, M. | |
Synthesis of pyrazolo[3,4-d]pyrimidine derivatives active against the T315I Abl mutation. | 1-gen-2012 | Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Maga, G.; Botta, M. | |
Synthesis of pyrazolo[3,4-d]pyrimidine derivatives endowed with activity against the T315I Abl mutation | 1-gen-2012 | Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; G., Maga; M., Botta | |
An update on dual Src/Abl inhibitors | 1-gen-2012 | Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Botta, M. | |
A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: From in silico screening to cyclodextrin formulation. | 1-gen-2012 | Radi, M; Evensen, L; Dreassi, E; Zamperini, C; Caporicci, M; Falchi, F; Musumeci, Francesca; Schenone, Silvia; Lorens, Jb; Botta, M. | |
Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors. | 1-gen-2012 | Musumeci, Francesca; Radi, M; Brullo, Chiara; Schenone, Silvia | |
Synthesis of pyrazolo[3,4-d]pyrimidines active on Bcr-Abl T315I mutation. | 1-gen-2013 | Musumeci, Francesca; Desogus, A.; Brullo, Chiara; Tintori, C.; Fallacara, A.; Maga, G.; Crespan, E.; Radi, M.; Schenone, Silvia | |
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors. | 1-gen-2013 | Mori, M; Tintori, C; Christopher, Rs; Radi, M; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Sanità, P; Delle Monache, S; Angelucci, A; Kissova, M; Crespan, E; Maga, G; Botta, M. | |
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors | 1-gen-2013 | G., Vignaroli; C., Zamperini; E., Dreassi; M., Radi; A., Angelucci; P., Sanità; E., Crespan; M., Kissova; G., Maga; Schenone, Silvia; Musumeci, Francesca; M., Botta | |
Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutant. | 1-gen-2013 | Radi, M; Tintori, C; Musumeci, Francesca; Brullo, Chiara; Zamperini, C; Dreassi, E; Fallacara, Al; Vignaroli, G; Crespan, E; Zanoli, S; Laurenzana, I; Filippi, I; Maga, G; Schenone, Silvia; Angelucci, A; Botta, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile